2026 Phyllis J. Kanki: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	60	3306	3045	1537	1405	284	15450

Research.com Recognitions

2008 - Member of the National Academy of Medicine (NAM)

Overview

Phyllis J. Kanki is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, with a particular focus on infectious diseases. Their research spans several subfields including infectious diseases, public health, environmental and occupational health, virology, epidemiology, and modeling and simulation.

The scientist's research topics cover a range of areas related to viral infections, with a notable emphasis on HIV/AIDS and SARS-CoV-2. Key topics include HIV/AIDS research and interventions, SARS-CoV-2 and COVID-19 research, HIV research and treatment, mosquito-borne diseases and control, viral infections and vectors, HIV/AIDS drug development and treatment, and SARS-CoV-2 detection and testing.

Phyllis J. Kanki has published in several venues, often contributing to journals that focus on infectious diseases and public health. Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), PLoS ONE, Emerging Microbes & Infections, Clinical Infectious Diseases, and Pediatric Cardiology.

Recent notable papers include:

"Reported Barriers to Healthcare Access and Service Disruptions Caused by COVID-19 in Burkina Faso, Ethiopia, and Nigeria: A Telephone Survey," 2021, American Journal of Tropical Medicine and Hygiene
"Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture," 2022, Journal of Clinical Microbiology
"Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort," 2022, Clinical Microbiology and Infection
"Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa," 2022, AIDS and Behavior
"Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria," 2020, PLoS ONE

Collaborative work has involved frequent co-authors such as Charlotte A. Chang, Donald J. Hamel, Beth Chaplin, Prosper Okonkwo, and Atiene S. Sagay, with whom this scientist has published multiple papers.

Phyllis J. Kanki is a member of the National Academy of Medicine, an honor received in 2008.

Best Publications

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

Daniel;NL Letvin;NW King;M Kannagi

1294
Citations
Reduced rate of disease development after HIV-2 infection as compared to HIV-1

Richard Marlink;Phyllis Kanki;Ibou Thior;Karin Travers

837
Citations
SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA

F. Barin;F. Denis;J.S. Allan;S. M'Boup

537
Citations
Slower heterosexual spread of HIV-2 than HIV-1.

P.J. Kanki;K.U. Travers;R.G. Marlink;M.E. Essex

509
Citations
Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression

Phyllis J. Kanki;Donald J. Hamel;Jean-Louis Sankalé;Chung-cheng Hsieh

490
Citations
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

P J Kanki;F Barin;S M'Boup;J S Allan

442
Citations
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

408
Citations
Serologic identification and characterization of a macaque T-lymphotropic rétrovirus closely related to HTLV-III

P. J. Kanki;M. F. McLane;N. W. King;N. L. Letvin

383
Citations
Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2

Stephen J. Popper;Abdoulaye Dieng Sarr;Karin U. Travers;Aissatou Guèye-Ndiaye

356
Citations
Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.

A.J. Nahmias;J. Weiss;X. Yao;F. Lee

309
Citations
Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal

Peter B. Gilbert;Ian W. McKeague;Geoffrey Eisen;Christopher Mullins

303
Citations
Isolation of T-Lymphotropic Retrovirus Related to HTLV-III/LAV from Wild-Caught African Green Monkeys

P. J. Kanki;J. Alroy;M. Essex

297
Citations
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Jonathan S. Allan;John E. Coligan;Tun-Hou Lee;Mary Frances McLane

291
Citations
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

287
Citations
Low Plasma Human Immunodeficiency Virus Type 2 Viral Load Is Independent of Proviral Load: Low Virus Production In Vivo

Stephen J. Popper;Abdoulaye Dieng Sarr;Aïssatou Guèye-Ndiaye;Souleymane Mboup

222
Citations
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

H Cao;P Kanki;J L Sankalé;A Dieng-Sarr

202
Citations
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients

Jesse A. Otegbayo;Babafemi O Taiwo;Titilola S Akingbola;Georgina N. Odaibo

200
Citations
High Levels of Tumor Necrosis Factor—α and Interleukin-1β in Bacterial Vaginosis May Increase Susceptibility to Human Immunodeficiency Virus

Katharine Sturm-Ramirez;Aïssatou Gaye-Diallo;Geoffrey Eisen;Souleymane Mboup

190
Citations
Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

Phyllis J. Kanki;Souleymane M'Boup;Dominique Ricard;Francis Barin

185
Citations
Lymphoma in macaques: association with virus of human T lymphotrophic family

T. Homma;P. J. Kanki;N. W. King;R. D. Hunt

180
Citations

Frequent Co-Authors

Souleymane Mboup Institute of Health Research, Epidemiological Surveillance and Training

Myron Essex Harvard University

Robert L. Murphy Northwestern University

Richard Marlink Rutgers, The State University of New Jersey

François Denis Hôpital Universitaire Dupuytren

Francis Barin Inserm

Eric J. Tchetgen Tchetgen University of Pennsylvania

Tobias F. Rinke de Wit University of Amsterdam

Tulio de Oliveira University of KwaZulu-Natal

Martine Peeters Institut de Recherche pour le Développement

External Links

Personal website of Phyllis J. Kanki

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees can open diverse career pathways in healthcare and research. Many students consider nursing-focused advanced degrees, which offer practical clinical skills and strong job prospects. For instance, exploring the easiest nurse practitioner degree programs can help students find flexible online options that suit different learning styles and schedules.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another valuable route, especially for those keen on mental health immunology intersections. The best online pmhnp programs frequently offer strong clinical placement opportunities, which are critical for hands-on experience and career readiness.

Cost is a significant factor when choosing a program. Prospective students should consider cheapest pmhnp programs to access quality education without excessive financial burden. This can be especially relevant for those balancing work or family commitments.

Finally, understanding potential earnings can guide career decisions. Reviewing the dnp salary by specialty offers insights into income expectations across states and specialties, helping graduates target the most rewarding career paths post-degree.